Lozada, Elenita D.

HRN: 25-48-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
CEFTRIAXONE 1G (VIAL)
04/06/2026
04/13/2026
IV
2g
Q24
T/c Enterocutaneous Fistula
Checking Initial Appropriateness 
04/06/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2026
04/13/2026
IV
500mg
Q8
T/c Enterocutaneous Fistula
Checking Initial Appropriateness 
04/07/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/07/2026
04/14/2026
IV
2.25grams
Q8H
S/P ExLap Sigmoid Adenocarcinoma
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: